The Telix Pharmaceuticals Ltd (ASX: TLX) share price is charging higher today.
Shares in the S&P/ASX 200 Index (ASX: XJO) diagnostic and therapeutic product developer closed on Friday trading for $14.64. In early morning trade on Monday, shares are swapping hands for $15.39 apiece, up 5.1%.
For some context, the ASX 200 is down 0.8% at this same time.
Here’s what’s catching investor interest.
Image source: Getty Images
Telix share price jumps on collaboration deal
The Telix share price is charging higher after the company announced it has entered into a strategic collaboration with United States based biotech giant Regeneron Pharmaceuticals Inc (NASDAQ: REGN) for cancer treatment.
The agreement will see the companies work together to…
